Premium
UPDATED EFFICACY AND SAFETY RESULTS OF ORELABRUTINIB IN THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL CELL LEUKEMIA
Author(s) -
Xu W.,
Song Y.,
Wang T.,
Yang S.,
Liu L.,
Hu Y.,
Zhang W.,
Zhou J.,
Gao S.,
Ding K.,
Zhang H.,
Zhu Z.,
Wang S.,
Xu B.,
Hu J.,
Liu T.,
Ji C.,
Xia Z.,
Li Y.,
Wang X.,
Zhao R.,
Zhang B.,
Li J.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.43_2880
Subject(s) - medicine , ighv@ , refractory (planetary science) , gastroenterology , chronic lymphocytic leukemia , regimen , dosing , phases of clinical research , leukemia , surgery , clinical trial , astrobiology , physics